Skip to main content
ANTEOTECH LTD logo

ANTEOTECH LTD — Investor Relations & Filings

Ticker · ADO ISIN · AU000000ADO8 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,281 across all filing types
Latest filing 2012-04-29 Interim / Quarterly Rep…
Country AU Australia
Listing ASX ADO

About ANTEOTECH LTD

https://anteotech.com

AnteoTech Ltd is a surface chemistry company specializing in the development of proprietary nanoglue technology. The company focuses on two primary sectors: life sciences and energy. In the life sciences division, AnteoTech utilizes its AnteoBind molecular linker technology to enhance the performance of point-of-care diagnostic tests, bioprocessing, and assay development by improving the binding of biomolecules to synthetic surfaces. In the energy sector, the company develops advanced materials for lithium-ion batteries, specifically focusing on silicon anodes. Its AnteoX additive is designed to improve the electrochemical performance and structural stability of high-silicon content anodes, addressing capacity loss and cycle life challenges. The company's core value proposition lies in its ability to manipulate surface interfaces at the molecular level to optimize performance in complex chemical and biological environments.

Recent filings

Filing Released Lang Actions
Quarterly Activities Report 7 pages 143.0KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C for the quarter ending 31 March 2012' and includes a CEO report for the quarter, detailed cash flow statements, and other financial data for the quarter ended 31 March 2012. It contains substantive financial data and analysis for a period shorter than a full fiscal year (quarterly). The document is not merely an announcement or a certification but a comprehensive quarterly report with financial statements and commentary. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2012-04-29 English
ADO launches new website 1 page 289.6KB
Regulatory Filings Classification · 95% confidence The document is a short announcement about Anteo Diagnostics launching a new webpage and improving investor communication. It does not contain any financial data, regulatory filings, or detailed reports. It is primarily an informational update about the company's website and communication channels. The document length is only 1551 characters, which is quite short and does not qualify as a full report or financial filing. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2012-04-19 English
Mix and Go at Emerging Technology Conference 2 pages 400.4KB
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Anteo Diagnostics will present a poster at a scientific conference about their Mix&Go™ surface chemistry technology. It contains no financial data, no regulatory filing references, no shareholder meeting information, no management or board changes, no earnings or capital updates, and no legal or governance content. It is a corporate announcement about a scientific presentation at a conference, not a financial or regulatory report. Therefore, it does not fit into any of the specific financial or regulatory filing categories. The best fit is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2012-04-17 English
Change of Director`s Interest Notice 2 pages 219.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares and options held before and after the change, the nature of the change (exercise of options), and the value of the transaction. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It does not contain financial performance data, management discussion, or regulatory announcements beyond director dealings. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 3661 characters, which is consistent with a detailed insider trading notice rather than a full financial report or announcement.
2012-04-01 English
Appendix 3B 8 pages 290.9KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3B' and is an announcement related to the issue of new securities, application for quotation of additional securities, and agreement with the ASX (Australian Securities Exchange). It details the class and number of securities issued, issue price, purpose of the issue, and other related information about securities quotation. There are no financial statements, management discussion, or earnings data present. The document is a formal announcement of a capital market transaction (new share issue and quotation application) rather than a financial report or earnings release. This fits the definition of a Share Issue/Capital Change announcement (SHA). The document length is over 10,000 characters, so it is not a mere report publication announcement. Therefore, the correct classification is SHA with high confidence.
2012-04-01 English
Investor Presentation 16 pages 493.7KB
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' and contains detailed information about Anteo Diagnostics' technology, market opportunities, commercialization strategy, recent developments, corporate structure, and financials. It is structured as a presentation with slides and images (omitted here) and includes forward-looking statements, market analysis, and company updates. There is no indication that this is a formal regulatory filing like an annual or interim report, audit report, or earnings release. The document is not a transcript of a call, nor is it a voting result or legal proceeding. It is clearly intended as a presentation to investors, focusing on business strategy, technology, and market potential. Therefore, the appropriate classification is 'Investor Presentation' (IP). The document length (over 14,000 characters) supports that it is a full presentation rather than a brief announcement or notice.
2012-03-29 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.